Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2025-12-25 @ 1:43 AM
NCT ID:
NCT06792994
Eligibility Criteria:
Inclusion Criteria:
* • Subjects must voluntarily sign and date an informed consent, ap-proved by an independent ethics committee (IEC)/institutional review board (IRB)
* Documented diagnosis of CLL at time point of inclusion in a first-line study of the GCLLSG (development of RT is not an exclusion criterion)
* First-line treatment was administered within one of these first-line studies of the GCLLSG (CLL13, CLL14, or CLL17).
* Subsequent therapy lines were either documented during the participa-tion in a first-line study of the GCLLSG or patient consented to have the subsequent therapy lines documented within this observational trial.
* Subjects are willing and able to comply with procedures required in this protocol.
Exclusion Criteria:
* • Patients without participation in one of the first-line studies of the GCLLSG (CLL13, CLL14, CLL17)
* Subjects with legal incapacity
* Subjects who are institutionalized by regulatory or court order
* Subjects who are in dependence to the sponsor or the investigator
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT06792994
Study Brief:
Protocol Section:
NCT06792994